QPS Expands with Three New Facilities
IQVIA Collaborates with Friends of Cancer Research
How ICH E6 (R2) Provides a Win/Win/Win through Risk-Based Study Execution
The industry-wide shift towards RBx is not only reducing risk, but improving oversight and boosting proactive, predictive decision making, writes Cluepoints' CCO, Patrick Hughes.
Elligo Health Research Partners with Jack Nathan Health
Certara Introduces Hasharc
Almac Group Participates in GCSBWG
ACT 2020 Media Kit
ObjectiveGI Establishes 10th “Center of Research Excellence”
WCG KMR Group Invites Biopharma Companies to Enroll in Cost Study
European Regulatory Framework and General Path to Market for ATMPs
Dave Li explores the current information on the commercialization of advanced therapy medicinal products.
Latest in Business and People News
The latest happenings of the past month in the industry, all in one place.
Signant Health Brings eConsent Solution to China
Less Disruption Please
Clinical research must deploy innovative, disruptive approaches without disrupting patients.
Avoca Group's Industry Research Report on Clinical Outsourcing: Spend, Models, and Measures
Findings from analyzed data from approximately 300 web survey responses representing over 200 global individual sponsor and provider organizations
A Name that European Clinical Trials Will Get to Know—and Maybe Love
Peter O'Donnell discusses the outpouring of support for Stella Kyriakides, who has been designated to lead European Union health policy for the next five years, and how she might need every bit of it.
SCORR Marketing and the Conference Forum Collaborate on CRAACO Conference
CROMSOURCE Consolidates Hybrid Services Model
Certara Launches Phoenix 8.2
Emerging Biopharma Tackles the Opioid Crisis
Dr. Steven Fox, CEO of Akelos Inc., discusses the challenges of developing new non-opioid medical products as the need intensifies as the crisis worsens.
Clinerion Partners with Volv Global
